CHARACTERISTIC OF ANTHRACYCLIN-RESISTANT STRAINS OF P388 LEUKEMIA

被引：0
|
作者：
GONCHAROVA, SA
DEMIDOVA, NS
SHIRYAEVA, OA
SHEVTSOVA, VN
KONOVALOVA, NP
机构：
来源：
EKSPERIMENTALNAYA ONKOLOGIYA | 1987年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：42 / 47
页数：6
相关论文
共 50 条
  • [1] CHEMOTHERAPEUTICAL SENSITIVITY OF THE ANTHRACYCLINE-RESISTANT STRAINS OF MICE P388 LEUKEMIA
    DEMIDOVA, NS
    GONCHAROVA, SA
    SHIRYAEVA, OA
    KONOVALOVA, NP
    EKSPERIMENTALNAYA ONKOLOGIYA, 1989, 11 (01): : 65 - 68
  • [2] EVALUATION OF NEW ANTHRACYCLINES ON P388-LEUKEMIA SENSITIVE (P388/S) OR RESISTANT (P388/R) TO DOXORUBICIN (DX)
    GERONI, CM
    PODESTA, A
    BARBIERI, BM
    GIULIANI, FC
    CASAZZA, AM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 280 - 280
  • [3] BIOCHEMICAL AND MORPHOLOGICAL-STUDIES IN P388 SENSITIVE AND DOXORUBICIN RESISTANT (P388 DX) LEUKEMIA-CELLS
    FACCHINETTI, T
    MALISANO, G
    SALARDI, S
    GERONI, C
    BELLINI, O
    ESPOSITO, G
    GIULIANI, FC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 343 - 343
  • [4] Effects of xanthine derivatives on the influx and efflux of doxorubicin in P388 and DOX-resistant P388 leukemia cells
    Sadzuka, Y
    Egawa, Y
    Sawanishi, H
    Miyamoto, K
    Sonobe, T
    TOXICOLOGY LETTERS, 2002, 135 (1-2) : 137 - 144
  • [5] LEUKEMIA P388-TUMORS RESISTANT TO VINCRISTINE (P388/VCR), ADRIAMYCIN (P388/ADR), OR ARABINOSYLCYTOSINE (P388/ARA-C) - CROSS-RESISTANCE (P388/VCR AND P388/ADR) AND COLLATERAL SENSITIVITY (P388/ARA-C) TO HOMOHARRINGTONINE (H) (NSC 141633)
    WILKOFF, LJ
    DULMADGE, EA
    TRADER, MW
    SCHABEL, FM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 199 - 199
  • [6] Redox-Active Compounds in the Therapy of Drug-Resistant Murine Leukemia P388 Strains
    Raevskaya, T. A.
    Soldatova, Yu. V.
    Goncharova, S. A.
    Faingold, I. I.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2024, 177 (02) : 266 - 270
  • [7] THERAPEUTIC SYNERGISM (TS) OF HOMOHARRINGTONINE (H) PLUS 5-FLUOROURACIL (FU) AGAINST LEUKEMIA P388 (P388/0) AND ARA-C-RESISTANT P388 (P388/ARA-C)
    LASTER, WR
    TRADER, MW
    SCHABEL, FM
    CORBETT, TH
    GRISWOLD, DP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 199 - 199
  • [8] CHARACTERIZATION OF P388 LEUKEMIA RESISTANT TO MITOMYCIN-C (MMC)
    ROSE, WC
    HUFTALEN, JB
    BRADNER, WT
    SCHURIG, JE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 260 - 260
  • [9] CHARACTERIZATION OF THE MECHANISM OF RESISTANCE OF A SUBLINE OF P388 LEUKEMIA RESISTANT TO AMSACRINE
    HOFMANN, GA
    BARTUS, JO
    MONG, SM
    SUNG, CM
    MATTERN, MR
    JOHNSON, RK
    MIRABELLI, CK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 269 - 269
  • [10] ISOLATION AND CHARACTERIZATION OF A MURINE P388 LEUKEMIA LINE RESISTANT TO THIARABINE
    Waud, William R.
    Parker, William B.
    Gilbert, Karen S.
    Secrist, John A., III
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2012, 31 (1-3): : 14 - 27
12345